Combination of rosiglitazone and donepezil for improvement...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4439 (2006.01) A61K 31/445 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2623204

The invention relates inter alia to a pharmaceutical composition comprising both rosiglitazone or a pharmaceutically acceptable salt thereof and donepezil or a pharmaceutically acceptable salt thereof which is of use in the treatment or prophylaxis of Alzheimer's disease or other dementias and mild cognitive impairment. The invention also relates to oral dosage forms comprising rosiglitazone or a pharmaceutically acceptable salt thereof and donepezil or a pharmaceutically acceptable salt thereof.

L'invention concerne notamment une composition pharmaceutique comprenant à la fois la rosiglitazone ou un sel de celle-ci pharmaceutiquement acceptable et le donépézil ou un sel de celui-ci pharmaceutiquement acceptable, que l'on utilise dans le traitement ou la prophylaxie de la maladie d'Alzheimer ou d'autres démences et déficiences cognitives légères. L'invention concerne également des formes posologiques orales comprenant la rosiglitazone ou un sel de celle-ci pharmaceutiquement acceptable et le donépézil ou un sel de celui-ci pharmaceutiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of rosiglitazone and donepezil for improvement... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of rosiglitazone and donepezil for improvement..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of rosiglitazone and donepezil for improvement... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2062870

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.